Rong Mu Selected Research

Rong Mu Research Topics

Disease

17	Rheumatoid Arthritis 09/2022 - 10/2005
15	Neoplasms (Cancer) 03/2019 - 10/2008
10	Infections 05/2021 - 12/2010
7	Inflammation (Inflammations) 01/2021 - 03/2010
5	Hepatocellular Carcinoma (Hepatoma) 02/2010 - 02/2005
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 12/2010
4	Hypertension (High Blood Pressure) 01/2021 - 04/2012
4	Meningitis 01/2019 - 01/2012
4	Arthritis (Polyarthritis) 01/2018 - 08/2008
4	Neoplasm Metastasis (Metastasis) 01/2016 - 02/2005
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2022 - 05/2017
3	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 01/2019
3	Fibrosis (Cirrhosis) 01/2021 - 01/2019
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2014
3	Hypoxia (Hypoxemia) 01/2019 - 01/2013
3	Breast Neoplasms (Breast Cancer) 07/2018 - 08/2008
2	Rheumatic Diseases (Rheumatism) 04/2021 - 01/2014
2	Diabetes Mellitus 01/2021 - 04/2012
2	Lupus Nephritis 01/2021 - 01/2021
2	Hyperplasia 01/2018 - 01/2013
2	Knee Osteoarthritis 01/2016 - 08/2010
2	Experimental Arthritis 01/2010 - 08/2008
1	Spontaneous Abortion (Miscarriage) 01/2022
1	Raynaud Disease (Raynaud's Disease) 01/2022
1	Stomach Ulcer (Gastric Ulcer) 05/2021
1	COVID-19 04/2021
1	Pathologic Processes 01/2021
1	Central Nervous System Lupus Vasculitis 05/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019
1	Myocardial Infarction 01/2019
1	Reperfusion Injury 12/2018
1	Brain Ischemia (Cerebral Ischemia) 12/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2018
1	Sepsis (Septicemia) 01/2018
1	Hyperuricemia 11/2017
1	Non-alcoholic Fatty Liver Disease 11/2017
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 02/2017
1	Venous Thrombosis (Deep-Vein Thrombosis) 02/2017

Drug/Important Bio-Agent (IBA)

13	CytokinesIBA 02/2020 - 08/2008
10	Interleukin-33IBA 07/2019 - 08/2008
7	AutoantibodiesIBA 01/2021 - 03/2010
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2008
4	gambogic acidIBA 01/2010 - 10/2008
3	AntibodiesIBA 01/2021 - 10/2005
3	EnzymesIBA 02/2020 - 02/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 02/2005
3	Interleukin-6 (Interleukin 6)IBA 01/2018 - 04/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 08/2008
3	5,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA 02/2010 - 11/2009
2	LipidsIBA 09/2022 - 01/2021
2	GlucocorticoidsIBA 01/2022 - 04/2012
2	iguratimodIBA 05/2021 - 01/2018
2	Oxygen (Dioxygen)IBA 04/2021 - 12/2018
2	UbiquitinIBA 05/2019 - 02/2011
2	Interleukin-1 (Interleukin 1)IBA 01/2019 - 03/2010
2	AntigensIBA 01/2019 - 08/2008
2	Antirheumatic Agents (DMARD)IBA 01/2018 - 05/2017
2	Uric Acid (Urate)IBA 11/2017 - 05/2017
2	Biological ProductsIBA 05/2017 - 08/2015
2	Immunoglobulin G (IgG)IBA 02/2017 - 01/2014
2	Peptides (Polypeptides)IBA 03/2016 - 10/2005
2	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2014 - 08/2012
2	Rheumatoid FactorIBA 04/2012 - 10/2005
1	Pharmaceutical PreparationsIBA 01/2022
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2022
1	Alanine Transaminase (SGPT)IBA 05/2021
1	IntegrinsIBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	pristane (pristan)IBA 01/2021
1	Muramidase (Lysozyme)IBA 02/2020
1	Messenger RNA (mRNA)IBA 02/2020
1	Biomarkers (Surrogate Marker)IBA 05/2019
1	HydrolasesIBA 05/2019
1	VimentinIBA 01/2019
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2019
1	Liraglutide FDA Link 01/2019
1	Surface Antigens (Surface Antigen)IBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	ImmunosorbentsIBA 01/2019
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2019
1	Interleukin-18 (Interleukin 18)IBA 01/2019
1	Dexmedetomidine FDA Link 12/2018
1	Glucose (Dextrose)FDA LinkGeneric 12/2018
1	Neuroprotective AgentsIBA 12/2018
1	Matrix Metalloproteinases (MMPs)IBA 07/2018
1	methylene diphosphonateIBA 01/2018
1	glucose utilization inhibitor (IGU)IBA 01/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2018
1	Technetium-99IBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 11/2017
1	DiureticsIBA 11/2017
1	CholesterolIBA 11/2017
1	ORALIT (ORS)IBA 05/2017
1	PhosphatidylserinesIBA 02/2017
1	Prothrombin (Factor II)IBA 02/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2016
1	SodiumIBA 01/2016

Therapy/Procedure

5	Therapeutics 03/2019 - 12/2009
1	Secondary Prevention 01/2021
1	Antibiotic Prophylaxis 01/2018